SOURCE: Deep Blue, Inc.

October 26, 2006 09:00 ET

Deep Blue Posts Details From Opinion Letter on Website

LAS VEGAS, NV -- (MARKET WIRE) -- October 26, 2006 -- Deep Blue, Inc. (PINKSHEETS: DPBL) has made available key excerpts from a third party opinion letter prepared for a private equity group as part of their pre-funding due diligence. The letter was prepared by Leonard Makowka, M.D., Ph.D. FRCS©, FACS. Dr. Makowka is a medical researcher, transplantation specialist, distinguished clinical surgeon, and entrepreneur recognized as one of the world's leading authorities in hepatic science. Among his many accomplishments, honors and distinctions, Dr. Makowka was the Chairman of the Department of Surgery and Director of Transplantation Services at Cedars Sinai Medical Center in Los Angeles, Professor of Surgery at UCLA and founder of the Comprehensive Liver Disease and Treatment Center at St. Vincent Medical Center in Los Angeles. He has retired from medical practice to pursue other interests. In the document, Dr. Makowka stated that, "Deep Blue has presented a strong argument for the potential efficacy of hyperbaric treatments (HT) modified by their proprietary techniques, as a method of altering the immune system..." He further stated, "The potential of this technology is too significant, and its benefits to medicine too important, not to receive a major commitment of attention and resources."

More information on the opinion letter can be found on the Deep Blue, Inc. website at www.deepblueinc.com in the section entitled "Important Information."

Matt Johnson, CEO, stated that, "After careful consideration, our discussions with a private equity group are now progressing at a pace that makes the Deep Blue management team believe that a major funding agreement will be completed in the very near future."

Deep Blue, Inc. (www.deepblueinc.com) is bringing to market an innovative patent-pending treatment, (Application Number 11/208,402), for HIV/AIDS and other viral infectious diseases

Cautionary Statement:

This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although Deep Blue, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein, the inclusion should not be regarded as a representation by Deep Blue, Inc., or any other person that the objectives and plans of Deep Blue, Inc. will be achieved.

Contact Information